Results 121 to 130 of about 4,705 (157)

Epidemiological and Clinical Behavior of Snakebite in the Pediatric Population, Associated with a Logistic Regression Model. [PDF]

Clin Pract
Revollo Vargas C, Bru-Cordero O, Pastor-Sierra K.   +2 more
europepmc   +1 more source

Biochemical and Biological Profiles of Bangladeshi Russell's Viper Snake Venom and Neutralizing Efficacy by Indian VINS Polyvalent Antivenom. [PDF]

J Toxicol
Hasan R, Manik H, Rahman MA, Shathi JH, Islam MT, Biswas MS, Hoque KMF.   +6 more
europepmc   +1 more source

Predictors and nomogram for amputation risk in pit viper snakebite envenoming at hospital admission. [PDF]

Sci Rep
Fu G, He F, Xiong K.
europepmc   +1 more source

Neurotoxic Sleight of Fang: Differential Antivenom Efficacy Against Mamba (<i>Dendroaspis</i> spp.) Venom Spastic-Paralysis Presynaptic/Synaptic vs. Flaccid-Paralysis Postsynaptic Effects. [PDF]

Toxins (Basel)
Jones L, Lay M, Seneci L, Hodgson WC, Koludarov I, Senoner T, Soria R, Fry BG.   +7 more
europepmc   +1 more source

Neurotoxicity of Sri Lankan Krait (<i>Bungarus ceylonicus</i>) and Common Krait (<i>Bungarus caeruleus</i>) Venoms and Their Neutralisation by Commercial Antivenoms In Vitro. [PDF]

Toxins (Basel)
Galappaththige J, Isbister GK, Maduwage K, Hodgson WC, Silva A.   +4 more
europepmc   +1 more source

A Case of Suspected Pit Viper Bite in Rural Nepal: Lessons for Snakebite Care. [PDF]

Cureus
Horton SD, Szarzanowicz KA, Bhatta N.
europepmc   +1 more source

Mapping Evidence on the Regulations Affecting the Accessibility, Availability, and Management of Snake Antivenom Globally: A Scoping Review. [PDF]

Trop Med Infect Dis
Majeed R, Bester J, Kgarosi K, Strydom M.   +3 more
europepmc   +1 more source

Sea snake envenomation in India: Urgent need for specific antivenom development. [PDF]

Indian J Med Res
Tripura U, Nagrale NV, Das S, Marak ACC, Singh OG, Tripura A.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Snake antivenom trial

Veterinary Record, 2014
WE would like to invite veterinary practitioners to take part in a clinical trial of Europe's first dedicated veterinary snake antivenom, ViperaVet. This is directed against the venom of four medically important Vipera species found throughout western Europe, including the adder ( Vipera berus) , Britain's only native venomous snake. Between September
Fiona, Bolton, Nicholas, Casewell, Ibrahim, Al-Abdulla   +2 more
openaire   +2 more sources

Antivenoms.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2013
The first advance on crude filtered immune serum or plasma for treating systemically envenomed bite victims was the use of IgG (predominantly equine) precipitated by salt treatment. This was followed by the development of F(ab')(2) antivenoms, prepared using pepsin digestion to remove both the highly reactive and nonspecific Fc part of the IgG molecule
R D, Theakston, D C, Smith
openaire   +1 more source